Delta-Fly Pharma,Inc. [4598.T]
TOKYO, Jun 01 (Pulse News Wire) – Delta-fly Pharma,inc. (4598.T) reported the exercise status of its 11th tranche warrant options for May.
The warrants, issued on February 02, 2026, were allocated to Macquarie Bank Limited. In May, 181 out of a total of 1,810 warrant options were exercised. As of the end of April, there were 1,629 unexercised warrant options remaining.
By the end of May, this number decreased to 1,665. During the month, 500 shares were transferred through warrant exercises on May 15 and May 22, while additional transfers occurred on May 26 and May 28. The company adhered to the exercise limitations set forth by the Tokyo Stock Exchange's Listing Regulations Article 434 and the Securities Association’s Rules Governing the Handling of Third-Party Allotment Rights Issues.
As of the issuance payment date, the outstanding share count was 1,100,000, with the exercise ratio standing at 2.79%.
🟢 Confidence: High AI-translated content.